Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,832 | 8,535 | 3,193 | 1,132 | 2,278 |
| Receivables | 3,095 | 3,058 | 3,496 | 4,107 | 1,322 |
| Inventories | 9,551 | 6,741 | 5,013 | 4,143 | 4,516 |
| TOTAL | $21,510 | $18,861 | $12,195 | $10,251 | $8,857 |
| Non-Current Assets | |||||
| PPE Net | 10,426 | 5,953 | 6,649 | 7,228 | 8,444 |
| Intangibles | 6,341 | 6,634 | 6,634 | 6,634 | 6,634 |
| Other Non-Current Assets | 2,618 | 3,701 | 711 | 844 | 468 |
| TOTAL | $19,386 | $16,288 | $13,995 | $14,705 | $15,545 |
| Total Assets | $40,896 | $35,149 | $26,190 | $24,957 | $24,402 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 311 | 354 | 411 | 652 | 654 |
| Accounts payable and accrued liabilities | 2,447 | 1,431 | 930 | 1,578 | 1,375 |
| Accrued Expenses | 5,048 | 4,693 | 4,271 | 4,821 | 3,714 |
| Other current liabilities | N/A | N/A | N/A | N/A | 150 |
| TOTAL | $7,834 | $6,694 | $5,813 | $8,640 | $6,906 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,562 | 1,389 | 1,741 | 1,800 | 3,327 |
| Deferred Revenues | 13 | 13 | 13 | 180 | 1,013 |
| Other Non-Current Liabilities | 522 | 1,812 | 2,439 | 3,802 | 16,438 |
| TOTAL | $4,102 | $3,233 | $4,225 | $5,661 | $20,004 |
| Total Liabilities | $11,936 | $9,927 | $10,038 | $14,301 | $26,910 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,013,915 | 1,011,282 | 1,009,177 | 840,404 | 828,389 |
| Common Shares | 1,014 | 1,011 | 1,009 | 841 | 825 |
| Retained earnings | -136,498 | -140,060 | -148,958 | -154,046 | -151,806 |
| Other shareholders' equity | -307 | -307 | -307 | 13,597 | -307 |
| TOTAL | $28,960 | $25,222 | $16,152 | $10,656 | $-2,508 |
| Total Liabilities And Equity | $40,896 | $35,149 | $26,190 | $24,957 | $24,402 |